| Name |
Description |
Page Modified |
| Modeling & Simulation Learn to Speak the Language: Modeling |
Presented at the 2006 AAPS Annual Meeting, San Antonio, TX |
Mon Nov 05 09:18:53 EST 2007 |
| Evaluation of the Bias and Precision of Bayesian Parameter Estimates When Applying a Phase I Model to Sparse Patient Data |
Presented at the 2004 AAPS Annual Meeting, Baltimore, MD |
Mon Nov 05 09:15:26 EST 2007 |
| Population PK/PD for Managers: From Identifying and Maximizing the Value-Add to Considerations for Implementation |
Presented at the 2003 AAPS Annual Meeting, Salt Lake City, UT |
Fri Nov 02 14:03:59 EDT 2007 |
| Change-Point Models: Some Considerations in Implementation |
Presented at the 2002 ECPAG Annual Meeting, Baltimore, MD |
Fri Nov 02 13:47:40 EDT 2007 |
| Evaluation of Covariate Effects on Population Pharmacokinetics (PPK) of Both Parent Drug and Metabolite(s) from Clinical Trial Data without Metabolite Administration or Excretion Sampling |
Presented at the 2002 AAPS Annual Meeting, Toronto, ON |
Mon Nov 05 09:02:45 EST 2007 |
| Uniqueness of Solutions to Compartmental Models of Population Pharmacokinetics for Drugs Ungergoing Complex Metabolism |
Presented at the 2002 ASCPT Annual Meeting, Atlanta, GA |
Mon Nov 05 09:04:13 EST 2007 |
| Problematic Estimation of Ka Using Peak-Trough Sampling Schemes |
Presented at the 2002 ECPAG Meeting, Baltimore, MD |
Mon Nov 05 09:08:16 EST 2007 |
| Rapid Assessment of Dataset Structures |
Presented at the 2002 PharmaSUG Annual Meeting, Salt Lake City, UT |
Mon Nov 05 09:11:47 EST 2007 |
| Influence of Dose Size on Dose Response Relationships for Linezolid Efficacy Using Monte Carlo Simulations |
Presented at the 2000 AAPS Annual Meeting, |
Fri Nov 02 14:41:25 EDT 2007 |
| The Application of Systematic Analysis for Identifying and Addressing the Needs of the Pharmacometric Process |
Presented at the PAGE Meeting, Copenhagen, Denmark |
Fri Nov 02 14:12:30 EDT 2007 |